Cancer is mostly treated with medications that target DNA repair. As a result of mutations in the DNA repair genes, DNA Repair Drugs Market are known to inhibit DNA repair enzymes and kill cancer cells with defective DNA repair. The market for DNA repair medications is broken down into categories based on drug type (including Olaparib, Rucaparib, Niraparib, and Talazoparib), application (including ovarian cancer, fallopian tube cancer, peritoneal cancer, breast cancer, and other application types), distribution channel (including hospital pharmacies, retail pharmacies, and other distribution channels), and geography (North America, Europe, Asia-Pacific and Rest of World). Asia-Pacific, Europe, North America, and the rest of the world. The report provides the value for the aforementioned segments (in USD million).
